(moderate) improvement for overall hair growth, hair volume and scalp coverage at day 180 compared to none in the placebo group. Hair Loss Quality of Life Questionnaire showed that hair thinning affected the self-esteem of all menopausal subjects at baseline and that by day 180, thirty-eight percent of the subjects in the active group no longer reported this concern. The majority of subjects in the active group responded positively to questions regarding ease of use with 97% reporting ease of adding the capsules to their daily routine, 94% reporting convenience of taking the capsules once daily instead of applying a topical
